Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying lung cancer patients who may be eligible for epidermal growth factor receptor (EGFR) mutation testing.

The New Zealand medical journal - 30 Aug 2013

Hicks Karalyn, Wong Conroy

Abstract excerpt

AIM: To characterise patients with non-squamous, non-small cell lung cancer (NSCLC) diagnosed at Counties Manukau District Health Board (CMDHB; South Auckland, New Zealand) to estimate the number who may be eligible for EGFR mutation testing. METHODS: Retrospective review of clinical records of 2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to DNA Mutational Analysis
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to EGFR gene

Share to Lung Neoplasms

Share to Mutation

Source

Identifiers

PMID: 24150265

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24150265-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying lung cancer patients who may be eligible for epidermal growth factor receptor (EGFR) mutation testing.PMID 24150265Read ↗

Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand.Semantic proximity Read ↗

Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand.Semantic proximity Read ↗

Factors associated with overall survival in patients with non-squamous NSCLC in New Zealand: A comparative analysis by EGFR gene mutation statusSemantic proximity Read ↗

Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries.Semantic proximity Read ↗

Clinical outcomes in patients with advanced epidermal growth factor receptor-mutated non-small-cell lung cancer in South Western Sydney Local Health District.Semantic proximity Read ↗

Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma.Semantic proximity Read ↗

Factors associated with overall survival in a population-based cohort of non- squamous NSCLC patients from northern New Zealand: A comparative analysis by EGFR mutation status.Semantic proximity Read ↗

Characteristics and overall survival of patients with early-stage non-small cell lung cancer: A cohort study in Denmark.Semantic proximity Read ↗

Trends and Outcomes of Non-Small-Cell Lung Cancer in Omani Patients: Experience at a university hospital.Semantic proximity Read ↗

EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital.Semantic proximity Read ↗

An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patientsSemantic proximity Read ↗

Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic malaysian patient population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.